Back to rankings
Brown Rudnick LLP

Brown Rudnick LLP

More information

United States • M&A/corporate and commercial

5

Venture capital and emerging companies

Brown Rudnick LLP stands out for one client because of how it ‘combines deep legal sophistication with a genuinely practical, business-first mindset’. The team advises startups and investors across a wide variety of sectors, including AI, cleantech, fintech, and life sciences. In Boston, co-lead Michael Cohen leads the life sciences group and has a particular focus on early-stage companies. Alongside Cohen, Washington DC-based Andrew J. Sherman co-heads the department and routinely advises emerging companies on M&A. Rounding out the leadership in New York, Jared Sorin frequently assists with venture financing rounds.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Brown Rudnick’s practice stands out because it combines deep legal sophistication with a genuinely practical, business-first mindset. The team (led for us by Michael Cohen) operates less like outside counsel and more like an extension of our internal leadership, with a strong understanding of how growth-stage and scaled technology companies actually operate. Michael Cohen is exceptionally responsive and consistently balances risk management with forward momentum.'

  • 'Compared to other firms, Brown Rudnick is less theoretical and more execution-oriented, particularly in moments that matter. The team collaborates well across disciplines, leverages technology efficiently, and adapts quickly as our needs evolve, which has made them a trusted long-term partner rather than a transactional service provider.’

  • ‘Michael Cohen stands out as an exceptional partner and has become a de facto member of our internal team. He is highly responsive, deeply understands our business, and consistently provides pragmatic, business-minded legal advice rather than academic analysis. That context and judgment are rare and extremely valuable, particularly as our company has evolved and faced complex, fast-moving issues.'

  • 'Michael Cohen's broader team at Brown Rudnick is strong and capable, and when we engage with them, the work product is thoughtful and high quality. What we value most is MJC’s availability, clarity, and ability to translate legal risk into actionable guidance. These are qualities that meaningfully differentiate him from many peers at other firms.’

Key clients

  • Aktis Oncology
  • Aline Technologies
  • Juxtapose
  • BEKHealth
  • Differential Ventures
  • Ospraie Ag Science
  • Frich
  • Berkeley Compute
  • DeepLook Medical
  • MPM BioImpact
  • AtVenu
  • Fundraise Up
  • Offsite Experience
  • Walkabout Ventures
  • Pace Ventures and Spectrum Value Management
  • Bullrock Energy Ventures
  • Beagle Innovations
  • JuneBrain
  • Envision Health Technologes

Work highlights

Represented biotechnology startup company Aktis Oncology in connection with an equity financing, announced concurrently with a significant multitarget discovery collaboration with Eli Lilly.
Represented Ospraie Ag Science, a VC fund focused on finding solutions for farmers, in multiple investments this past year
Practice head

Michael Cohen; Andrew J. Sherman; Jared Sorin

Other key lawyers

David Haber; Scott Smedresman; Matthew Uretsky